Zhang RY - Search Results

1

Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury.

Liu Y, Zhang RY, Zhao J, Dong Z, Feng DY, Wu R, Shi M, Zhao G. Liu Y, et al. Among authors: zhang ry. Int J Mol Sci. 2015 Jun 24;16(7):14395-408. doi: 10.3390/ijms160714395. Int J Mol Sci. 2015. PMID: 26114390 Free PMC article.

2

Large HBV Surface Protein-Induced Unfolded Protein Response Dynamically Regulates p27 Degradation in Hepatocellular Carcinoma Progression.

Guo Y, Shao J, Zhang R, Han M, Kong L, Liu Z, Li H, Wei D, Lu M, Zhang S, Zhang C, Wei H, Chen Z, Bian H. Guo Y, et al. Int J Mol Sci. 2023 Sep 7;24(18):13825. doi: 10.3390/ijms241813825. Int J Mol Sci. 2023. PMID: 37762128 Free PMC article.

3

Rab11a regulates MMP2 expression by activating the PI3K/AKT pathway in human hepatocellular carcinoma cells.

Zhang ZY, Lu M, Liu ZK, Li H, Yong YL, Zhang RY, Chen ZN, Bian H. Zhang ZY, et al. Among authors: zhang ry. Pathol Res Pract. 2020 Sep;216(9):153046. doi: 10.1016/j.prp.2020.153046. Epub 2020 Jun 1. Pathol Res Pract. 2020. PMID: 32825931

4

Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis.

Lv JJ, Wang H, Cui HY, Liu ZK, Zhang RY, Lu M, Li C, Yong YL, Liu M, Zhang H, Zhang TJ, Zhang K, Li G, Nan G, Zhang C, Guo SP, Wang L, Chen ZN, Bian H. Lv JJ, et al. Among authors: zhang tj, zhang ry, zhang c, zhang k, zhang h. Front Cell Dev Biol. 2021 Jan 8;8:609090. doi: 10.3389/fcell.2020.609090. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33490072 Free PMC article.

5

Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma.

Yong YL, Zhang RY, Liu ZK, Wei D, Shang YK, Wu J, Zhang ZY, Li C, Chen ZN, Bian H. Yong YL, et al. Among authors: zhang ry, zhang zy. J Pathol. 2019 Oct;249(2):255-267. doi: 10.1002/path.5316. Epub 2019 Aug 6. J Pathol. 2019. PMID: 31215640

6

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.

Liu ZK, Li C, Zhang RY, Wei D, Shang YK, Yong YL, Kong LM, Zheng NS, Liu K, Lu M, Liu M, Hu CX, Yang XZ, Chen ZN, Bian H. Liu ZK, et al. Among authors: zhang ry. Mol Cancer. 2021 May 27;20(1):79. doi: 10.1186/s12943-021-01377-9. Mol Cancer. 2021. PMID: 34044846 Free PMC article.

7

CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia.

Zheng NS, Zhao XY, Wei D, Miao JL, Liu ZK, Yong YL, Zhang RY, Guo YX, He L, Wang B, Sun XX, Yang HJ, Zhang TJ, He Q, Li XM, Zhang H, Hou R, Lin P, Xu YM, Huang XJ, Chen ZN, Bian H. Zheng NS, et al. Among authors: zhang tj, zhang ry, zhang h. Cancer Lett. 2022 Aug 28;542:215762. doi: 10.1016/j.canlet.2022.215762. Epub 2022 May 31. Cancer Lett. 2022. PMID: 35659513

8

Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy.

Zhang Z, Jiang J, Wu X, Zhang M, Luo D, Zhang R, Li S, He Y, Bian H, Chen Z. Zhang Z, et al. Front Med. 2019 Feb;13(1):57-68. doi: 10.1007/s11684-019-0683-y. Epub 2019 Feb 5. Front Med. 2019. PMID: 30721445

9

Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy.

Zhang RY, Wei D, Liu ZK, Yong YL, Wei W, Zhang ZY, Lv JJ, Zhang Z, Chen ZN, Bian H. Zhang RY, et al. Among authors: zhang zy, zhang z. Front Cell Dev Biol. 2019 Oct 11;7:233. doi: 10.3389/fcell.2019.00233. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31681766 Free PMC article.

10

Adoptive cell transfer therapy for hepatocellular carcinoma.

Zhang R, Zhang Z, Liu Z, Wei D, Wu X, Bian H, Chen Z. Zhang R, et al. Front Med. 2019 Feb;13(1):3-11. doi: 10.1007/s11684-019-0684-x. Epub 2019 Jan 18. Front Med. 2019. PMID: 30659408 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page